{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:45:59Z","timestamp":1792511159499,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.drugalcdep.2014.05.011","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T07:44:38Z","timestamp":1401695078000},"page":"33-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry"],"prefix":"10.1016","volume":"142","author":[{"given":"Michael S.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Kinlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence T.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"O\u2019Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Vocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0005","series-title":"Categorical Data Analysis","author":"Agresti","year":"1990"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience","volume":"171","author":"Alford","year":"2011","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2010.11.029","article-title":"Risk factors for all-cause, overdose and early deaths after release from prison in Washington state","volume":"117","author":"Binswanger","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1940-0640-7-3","article-title":"Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors","volume":"7","author":"Binswanger","year":"2012","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0025","series-title":"Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction, TIP 40","author":"Center for Substance Abuse Treatment (CSAT)","year":"2004"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2008.976","article-title":"Treating drug abuse and addiction in the criminal justice system: improving public health and safety","volume":"301","author":"Chandler","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0035","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1526-4637.2010.00877.x","article-title":"Post-marketing surveillance of methadone and buprenorphine in the United States","volume":"11","author":"Dasgupta","year":"2010","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0040","series-title":"Prisons and Drugs: A Global Review of Incarceration, Drug Use and Drug Services","author":"Dolan","year":"2007"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0045","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1360-0443.2005.01050.x","article-title":"Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection","volume":"100","author":"Dolan","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","article-title":"Substance abuse and dependence in prisoners: a systematic review","volume":"101","author":"Fazel","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/ADM.0b013e31814b8880","article-title":"Buprenorphine-naloxone treatment for pre-release opioid-dependent inmate in Puerto Rico","volume":"1","author":"Garcia","year":"2007","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0060","series-title":"A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Findings at 12 Months Post Release","author":"Gordon","year":"2008"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.psc.2010.01.004","article-title":"Substance abuse in women","volume":"33","author":"Greenfield","year":"2010","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0070","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/sim.1047","article-title":"A solution to the problem of separation in logistic regression","volume":"21","author":"Heinze","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0075","series-title":"Applied Logistic Regression","author":"Hosmer","year":"1989"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0080","series-title":"The War on Drugs IV","author":"Inciardi","year":"2008"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.07.019","article-title":"Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians","volume":"120","author":"Johanson","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/YCO.0b013e3282fc985c","article-title":"Drug use and health among prison inmates","volume":"21","author":"Kanato","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0095","series-title":"Opioid Substitution Treatment in Custodial Settings. A Practical Guide","author":"Kastelic","year":"2008"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0100","series-title":"Lowinson & Ruiz's Substance Abuse: A Comprehensive Textbook","first-page":"881","article-title":"Incarcerated populations","author":"Kinlock","year":"2011"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10509670903534951","article-title":"Developing and implementing a new prison-based buprenorphine treatment program","volume":"49","author":"Kinlock","year":"2010","journal-title":"J. Offender Rehabil."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: results at 12 months post-release","volume":"37","author":"Kinlock","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/002204260303300406","article-title":"Prediction of the criminal activity of incarcerated drug-abusing offenders","volume":"33","author":"Kinlock","year":"2003","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/PAF.0b013e3181873784","article-title":"Drugs, detention, and death: a study of the mortality of recently released prisoners","volume":"30","author":"Krinsky","year":"2009","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/08897077.2011.620475","article-title":"Buprenorphine-naloxone maintenance following release from jail","volume":"33","author":"Lee","year":"2012","journal-title":"Subst. Abuse"},{"issue":"1","key":"10.1016\/j.drugalcdep.2014.05.011_bib0130","first-page":"S14","article-title":"Frequency of re-incarcerations in the same detention center: role of substitution therapy. A preliminary retrospective analysis","volume":"153","author":"Levasseur","year":"2002","journal-title":"Ann. Med. Interne (Paris)"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0140","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0150","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0155","unstructured":"Messina, N. 2009. Implications for Criminal Justice Involved Women with Co-Occurring Substance Abuse and Mental and Physical Health Problems. White Paper prepared for the Co-Occurring Joint Action Council (COJAC), the Department of Alcohol and Drug Programs (ADP), and Department of Mental Health (DMH). http\/\/www.aodpolicy.org\/COD.htm."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0160","first-page":"5","article-title":"Evaluation of opioid-dependent prisoners in oral opioid maintenance therapy","volume":"12","author":"Metz","year":"2010","journal-title":"Heroin Addict. Relat. Clin. Prob."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/ADM.0b013e318233d621","article-title":"Comparison of buprenorphine treatment for opioid dependence in three settings","volume":"6","author":"Miotto","year":"2012","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2011.09.009","article-title":"African American patients seeking treatment in the public sector: characteristics of buprenorphine vs. methadone patients","volume":"122","author":"Mitchell","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10550880903014767","article-title":"Diversion of buprenorphine\/naloxone coformulated tablets in a region with high prescribing prevalence","volume":"28","author":"Monte","year":"2009","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0180","series-title":"Drug Use and Dependence, State and Federal Prisoners, 2004","first-page":"NCJ 213530","author":"Mumola","year":"2006"},{"issue":"2","key":"10.1016\/j.drugalcdep.2014.05.011_bib0185","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/002204261004000210","article-title":"Self-report of longitduinal substance use: a comparison of the UCLA natural history interview and the addiction severity index","volume":"40","author":"Murphy","year":"2010","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0190","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3109\/10826089809059323","article-title":"A long-term program of research on drug use and crime","volume":"33","author":"Nurco","year":"1998","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/00952997509002733","article-title":"Studying addicts over time: methodology and preliminary findings","volume":"2","author":"Nurco","year":"1975","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0200","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/948789","article-title":"Distance traveled and cross-state commuting to opioid treatment programs in the United States","author":"Rosenblum","year":"2011","journal-title":"J. Environ. Public Health"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0205","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.drugpo.2006.11.015","article-title":"The impact of substitution treatment in prisons \u2013 a literature review","volume":"18","author":"Stallwitz","year":"2007","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v26n03_01","article-title":"Buprenorphine misuse, abuse, and diversion: when will we ever learn?","volume":"26","author":"Stimmel","year":"2007","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7517-7-17","article-title":"Drug use and opioid substitution treatment for prisoners","volume":"7","author":"Stover","year":"2010","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0220","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1360-0443.2006.01475.x","article-title":"Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison","volume":"101","author":"Strang","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jsat.2006.12.019","article-title":"Drug treatment services for adult offenders: the state of the state","volume":"32","author":"Taxman","year":"2007","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0230","series-title":"Lowinson & Ruiz's Substance Abuse: A Comprehensive Textbook","first-page":"437","article-title":"Buprenorphine in the treatment of opioid dependence","author":"Tompkins","year":"2011"},{"key":"10.1016\/j.drugalcdep.2014.05.011_bib0235","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsat.2013.02.005","article-title":"Initiation of buprenorphine during incarceration and retention in treatment upon release","volume":"45","author":"Zaller","year":"2013","journal-title":"J. Subst. Abuse Treat."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161400893X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161400893X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T14:54:27Z","timestamp":1538578467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161400893X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":47,"alternative-id":["S037687161400893X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.05.011","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}